[The role of incomplete clearance of apoptotic cells in the etiology and pathogenesis of SLE]
- PMID: 20107814
- DOI: 10.1007/s00393-009-0603-7
[The role of incomplete clearance of apoptotic cells in the etiology and pathogenesis of SLE]
Abstract
Systemic lupus erythematosus (SLE) is a complex prototypic autoimmune disease that is based on genetic factors (complement deficiencies) and is influenced by gender (female), environment (infections and UV irradiation), as well as random events (somatic mutations). The course of the disease is influenced by genes (e.g. FcgammaRIIA) and behaviour (sun-exposure). Inefficient clearance of dying cells and subsequent accumulation of apoptotic cell remnants is an intrinsic defect causing the permanent presence of cellular debris responsible for the initiation of autoimmunity. We favour the hypothesis that post-apoptotic debris accumulates in germinal centres, activates complement, and serves as a survival signal for B-cells that had stochastically become autoreactive in the process of somatic hypermutation (etiology). In the presence of autoantibodies against apoptotic cells or adaptor molecules the accumulation of post-apoptotic remnants (SNEC) causes immune complex formation and their pathological elimination, maintaining auto-inflammation. The SLE-type autoimmunity addresses nucleic acid-containing complex antigens (viromimetica). Autoantibody-protein-nucleic-acid complexes are likely to be mistaken for opsonised viruses. As a consequence, the immune system responds with the production of type-I interferons, a hallmark of SLE (pathogenesis). We conclude that the pathogenicity of autoantibodies is strongly increased if autoantigens are accessible and immune complexes are formed, which may be considered a binary pyrogen formed from less pro-inflammatory components. The accessibility of cognate autoantigens is likely to be related to impaired or delayed clearance of apoptotic cells.
Similar articles
-
The role of defective clearance of apoptotic cells in systemic autoimmunity.Nat Rev Rheumatol. 2010 May;6(5):280-9. doi: 10.1038/nrrheum.2010.46. Nat Rev Rheumatol. 2010. PMID: 20431553 Review.
-
Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE.Autoimmun Rev. 2010 Nov;10(1):38-42. doi: 10.1016/j.autrev.2010.08.015. Epub 2010 Sep 9. Autoimmun Rev. 2010. PMID: 20817127 Review.
-
[Pathogenesis of systemic lupus erythematosus (SLE)--the central role of complement].Ther Umsch. 2005 May;62(5):285-91. doi: 10.1024/0040-5930.62.5.285. Ther Umsch. 2005. PMID: 15945218 Review. German.
-
Circulating microparticles in systemic Lupus Erythematosus.Dan Med J. 2012 Nov;59(11):B4548. Dan Med J. 2012. PMID: 23171755 Review.
-
Complement deficiencies and systemic lupus erythematosus.Autoimmunity. 2007 Dec;40(8):560-6. doi: 10.1080/08916930701510673. Autoimmunity. 2007. PMID: 18075790 Review.
Cited by
-
Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.Cancer Res. 2018 Oct 1;78(19):5600-5617. doi: 10.1158/0008-5472.CAN-18-0562. Epub 2018 Aug 15. Cancer Res. 2018. PMID: 30111533 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials